COPYRIGHT AND CITATION CONSIDERATIONS FOR THIS THESIS/ DISSERTATION o Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. o NonCommercial — You may not use the material for commercial purposes. o ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. How to cite this thesis Surname, Initial(s). (2012). Title of the thesis or dissertation (Doctoral Thesis / Master’s Dissertation). Johannesburg: University of Johannesburg. Available from: http://hdl.handle.net/102000/0002 (Accessed: 22 August 2017).
114
Embed
The Effects of Ischaemic Compression versus Therapeutic Massage ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
COPYRIGHT AND CITATION CONSIDERATIONS FOR THIS THESIS/ DISSERTATION
o Attribution — You must give appropriate credit, provide a link to the license, and indicate ifchanges were made. You may do so in any reasonable manner, but not in any way thatsuggests the licensor endorses you or your use.
o NonCommercial — You may not use the material for commercial purposes.
o ShareAlike — If you remix, transform, or build upon the material, you must distribute yourcontributions under the same license as the original.
How to cite this thesis
Surname, Initial(s). (2012). Title of the thesis or dissertation (Doctoral Thesis / Master’s Dissertation). Johannesburg: University of Johannesburg. Available from: http://hdl.handle.net/102000/0002 (Accessed: 22 August 2017).
Objective and subjective data were collected by the researcher and analysed by a
consultant from STATKON (located on the University of Johannesburg Kingsway
Campus). The analyst used normality tests, descriptive data and clinical statistics to
summarise, organise and interpret the data gathered from the entire sample of 30
participants. The Shapiro-Wilk test was used to check normality of the variables.
Intra-group analysis consisted of one-way repeated measures ANOVA and the
Friedman test when the data was distributed non-parametrically. This test
determined the possibility of any statistically significant changes pre and post
treatment over the three-week trial period and when (i.e. between which visits) those
changes occurred. Inter-group analysis was done by the use of the independent t-
test (for data distributed parametrically) and the Mann-Whitney U test (for data
distributed non-parametrically) in order to check statistically significant differences
between the two groups.
32
3.9 ETHICAL CONSIDERATIONS
All participants that took part in this study were requested to read the information
form (Appendix B) and sign the consent form (Appendix C) specific to this study. The
information form outlined the details of the researcher, purpose of the study and
benefits of participating in the study, as well as participant assessment and treatment
procedure.
Any risks, benefits and discomforts related to the treatment involved were explained
and the participants’ safety were ensured at all times (prevention of harm). The
information and consent forms stipulated that the participant’s privacy was protected
by ensuring their anonymity (no names/personal information were taken) and
standard doctor-patient confidentiality was ensured for the duration of the study. The
participant was provided with a research number and a research file that was kept
safe within the chiropractic clinic to ensure confidentiality. After the study, all the
information was converted to data and could not be traced back to the participant.
Participants were informed that their participation was on a voluntary basis only and
that they were free to withdraw at any stage during the study without penalty. Results
of the study will be made available to participants on request.
Risk regarding with ischemic compression therapy and percussive massage therapy
with a device is minimal. Some participants experienced slight discomfort and pain
during ischemic compression and percussive massage, which is normal. Some
participants reported itching with the percussive massage device. The pain,
discomfort and itching never exceeded the participant’s pain tolerance. Post-
treatment stiffness, pain and red temporary discoloration of the skin were expected,
as these are normal responses.
Professor Christopher Stein (Chairperson of the Faculty of Health Sciences
Research Ethics Committee at the University of Johannesburg) was asked for
permission to use students on the campus as participants in this study, which was
granted. The treatment took place on the University of Johannesburg Doornfontein
campus after the necessary Higher Degrees Committee clearance letter (Appendix
33
K) and Ethics Committee clearance letter (Appendix L) were obtained. Participants
were referred to appropriate health care professionals when necessary.
A similarity report for this study has been obtained through the Turnitin programme
of the University of Johannesburg (Appendix M). This dissertation has been edited
by a qualified language practitioner (Appendix N).
34
CHAPTER FOUR: RESULTS
4.1 INTRODUCTION
The results presented in this chapter were obtained during the clinical study. The
sample group consisted of 30 participants, 15 of whom received ischemic
compression (group A) and 15 of whom received therapeutic massage with a
percussive device (group B).
All the subjective and objective data captured were analysed and tabulated in order
to capture any clinically or statistically significant improvements that occurred in each
of the individual treatment groups as well as to determine any significant differences
between the two treatment groups.
The analyses of this study were based on three readings that were recorded at the
initial visit, visit four and visit seven and included:
Demographical data analysis of age and gender
Subjective data analysis
o NPRS
Objective data analysis
o pressure algometer
o baseline goniometer
The probability value (p-value) for all the test was set at 0.05, representing the level
of significance. Therefore, only a p-value that that was ≤ 0.05 was statistically
significant.
The method used for the clinical analysis of the data with regards to the percentage
increase or decrease of the mean values over a treatment period was as follows:
Percentage increase of the mean value over a treatment period:
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒 =New Amount−Original Amount
Original Amount 𝑥 100
35
Percentage decrease of mean value over treatment period:
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑑𝑒𝑐𝑟𝑒𝑎𝑠𝑒 =Original Amount−New Amount
Original Amount 𝑥 100
4.1.1 Normality testing
The Shapiro-Wilk test was used to establish the normality, and is used for sample
sizes of ≤ 50 participants. The statistics found were not normally distributed, due to
the small sample size and independent sample groups, therefore non-parametric
testing was applied for inter-and intragroup analysis.
4.1.2 Descriptive and clinical analysis
The descriptive and clinical statistics were used to summarise and describe the data
collected.
4.1.3 Intragroup analysis
The Friedman test, a non-parametric test, was used for the intragroup analysis. It
was used to determine if there was a significant difference in any of the two individual
groups as well as the total sample over a time period. To determine when these
differences occurred, i.e. between which visits, the non-parametric Wilcoxon signed-
rank test was done to establish any statistical significance.
4.1.4 Intergroup analysis
The intergroup analysis was done using the Mann-Whitney U test, a non-parametric
test used to establish the mean equivalence. The test compares the mean rank
values of the two individual groups, to determine whether one group is superior to
the other.
36
4.2 DEMOGRAPHIC DATA ANALYSIS
The sample group of this study consisted of 15 males and 15 females. Group A
consisted of 15 participants; seven females and eight males. Group B consisted of
15 participants; eight females and seven males. The mean age, demonstrated in
table 4.1, was 24.93 years for group A and 25.2 years for group B, making the total
sample group mean age 25.07 years.
Table 4.1 Demographic Data within the Sample of 30 Participants
Data Group A Group B Combined Total
Age Distribution (Years)
23-30 21-32 21-32
Mean age (Years)
24.93 25.2 25.07
Gender distribution
3.6 Female
8 Male 3.7 Female
7 Male 15 Female
15 Male
4.3 SUBJECTIVE DATA ANALYSIS
The subjective data for this study were obtained using the NPRS.
4.3.1 Intragroup analysis of the Numerical Pain Rating Scale
The NPRS was used to capture the participants’ perceived pain intensity on a scale
of 0 to 10. The Friedman test was used to compare that results from each individual
group over time. To detect exactly where any differences occurred over the time
within each individual group, the Wilcoxon signed-rank test was used. The test was
37
able to detect the differences between the first and fourth visits, fourth and seventh
visits as well as the first and seventh visits.
4.3.1.1 Numerical Pain Rating Scale statistics for group A
Group A had a mean value of 5.80 at the first consultation, 3.93 at fourth consultation
and at 1.47 at the seventh. Based on the mean NPRS values obtained for group A,
a percentage was calculated in order to determine whether there was an overall
improvement or a lack thereof. Group A showed a 74.66% change.
Table 4.2 Friedman Test Changes in NPRS Values of Group A
Group A: Friedman Test
Visit Mean Rank P-Value
Visit 1 2.97 0.000 Visit 4 2.03
Visit 7 1.00
As table 4.2 demonstrates, group A had a mean rank value of 2.97 at visit 1, 2.03 at
visit 4 and 1.00 at visit 7. The Friedman test for group A showed a p-value of 0.000, which was statistically significant (p≤0.05).
To detect exactly where any differences occurred over the time within group A, the
Wilcoxon signed-rank test was used. The test was able to detect the differences
between the first and fourth visits, the fourth and seventh visits, and the first and
seventh visits.
38
Table 4.3 Wilcoxon Signed-Rank Test for Group A
Group A: Wilcoxon Signed-Rank Test
Visit P-Value
Visit 1 – Visit 4 0.001
Visit 4 – Visit 7 0.001
Visit 1 – Visit 7 0.001
The NPRS values for group A demonstrated in table 4.3 show a statistically
significant improvement for the intervals between the first and fourth visits (p=0.001),
between the fourth and seventh visits (p=0.001), and between the first and seventh
visits (p=0.001). Therefore, the change in scores from group A showed a significant
difference (p≤0.05) that occurred over the time intervals.
4.3.1.2 Numerical Pain Rating Scale Statistics for group B
Group B had a mean value of 5.87 at the first consultation, 3.93 at the fourth
consultation and 1.40 at the seventh consultation.
Based on the mean NPRS values obtained for group B, a percentage was calculated
in order to determine whether there was an overall improvement or a lack thereof.
Group B showed a 76.15% change.
Table 4.4 Friedman Test Changes in NPRS Values of Group B
Group B: Friedman Test
Visit Mean Rank P-Value
Visit 1 2.97 0.000 Visit 4 2.00
Visit 7 1.03
39
To detect exactly where any differences occurred over the time within group B, the
Wilcoxon signed-rank test was used. The test was able to detect the differences
between the first and fourth visits, the fourth and seventh visits, and the first and
seventh visits.
Table 4.5 Wilcoxon Signed-Rank Test for Group B
Group B: Wilcoxon Signed-Rank Test
Visit P-Value
Visit 1 – Visit 4 0.001
Visit 4 – Visit 7 0.001
Visit 1 – Visit 7 0.001
The NPRS values for group B demonstrated in table 4.5 show a statistically
significant improvement for the intervals between the first and fourth visits (p=0.001),
the fourth and seventh visits (p=0.001) and the first and seventh visits (p=0.001).
Therefore, group B showed a significant improvement (p≤0.05), which occurred over
all time intervals.
40
4.3.1.3 Clinical analysis
Figure 4.1 Bar Graph Representing the NPRS Values of Each Visit for Both Groups
Figure 4.1 compares the NPRS mean values for both groups over time. The x-axis
represents the NPRS results at the first, fourth and seventh visits. The y-axis
represents the improvement seen on the scale of 0 to 10. These values were
discussed
4.3.2 Intergroup analysis of the Numerical Pain Rating Scale
A comparison was made between the two groups at specific intervals using the
Mann-Whitney U test. Comparisons between group A and group B were made
between the intervals of the first, fourth and seventh visits. Results showed that the
scores from the first visit had a p-value of 0.708, the fourth visit had a p-value of
0.931 and the seventh visit had a p-value of 0.983. Therefore, no significant
differenced (p>0.05) occurred between the two groups at the specific time intervals.
5.8
3.93
1.47
5.87
3.93
1.4
0
1
2
3
4
5
6
7
Visit 1 Visit 4 Visit 7
NPR
S Va
lues
Visits
Group A Group B
41
4.4 OBJECTIVE DATA ANALYSIS
Objective data for this study was obtained using the pressure algometer and
baseline goniometer.
4.4.1. Intragroup analysis of pressure algometer
4.4.1.1 Pressure algometer statistics for group A
Table 4.6 Group A Column Statistics of the Pressure Algometer
Group A: Pressure Algometer kg/cm²
Readings Mean Maximum Minimum Median Std. Deviation
Visit 1 5.04 6.0 4.5 5.0 0.38
Visit 4 6.21 8.5 4.0 6.0 1.00
Visit 7 7.43 9.0 5.5 7.3 1.04
Table 4.6 illustrates the pressure algometer mean, maximum, minimum, median and
standard deviation values of group A. Group A at the first visit had a mean pressure
algometer reading of 5.04 kg/cm², 6.21 kg/cm² at the fourth visit, and 7.43 kg/cm² at
the seventh visit. Therefore, the mean percentage increase in pain pressure
threshold measured by the pressure algometer for group A was 47.42 %.
42
Table 4.7 Group A Friedman Test for Changes in Pressure Algometer Mean Values
Group A: Friedman Test
Group Reading Mean Rank P-Value
Group A
Visit 1 1.13 0.000 Visit 4 2.0
Visit 7 2.87
Table 4.7 demonstrates the non-parametric Friedman test used to determine if there
were any changes of any statistical significance in pain pressure threshold measured
by the pressure algometer within group A over the trial period.
Group A had a mean rank pressure algometer value of 1.13 at the first visit, 2.0 at
the fourth visit, and 2.87 at the seventh visit. The p-value of 0.00 shows the
improvement was statistically significant (p≤0.05).
Table 4.8 Group A Wilcoxon Signed-Rank Test for Changes over Time (Pressure Algometer)
Group A: Wilcoxon Signed-Rank Test
Visits P-Value
Visit 1 – Visit 4 0.001
Visit 4 – Visit 7 0.003
Visit 1 – Visit 7 0.001
Table 4.8 demonstrates the results of the Wilcoxon signed-rank test, a non-
parametric test used to determine between which visits the statistically significant
improvement in pain pressure threshold measured by the pressure algometer
occurred in group A. Results indicate that the statistically significant difference
43
(p≤0.05) was found between visit 1 and visit 4 (p=0.001), between visit 4 and visit 7
(p=0.003), and between visit 1 and visit 7 (p=0.001).
4.4.1.2 Pressure algometer statistics for group B
Table 4.9 Group B Column Statistics of the Pressure Algometer
Group B: Pressure Algometer (kg/cm²)
Readings Mean Maximum Minimum Median Std. Deviation
Visit 1 4.54 5.7 3.2 4.7 0.748
Visit 4 5.99 7.3 4.7 6.0 0.729
Visit 7 7.25 8.5 5.7 7.0 0.835
Table 4.9 illustrates the pressure algometer mean, maximum, minimum, median and
standard deviation values of Group B. Group B had a mean pressure algometer
reading of 4.54 kg/cm² at the first visit, 5.99 kg/cm² at the fourth visit, and 7.25 kg/cm²
at the seventh visit. Therefore, the mean percentage increase in pain pressure
threshold measured by the pressure algometer for group B was 59.69%.
Table 4.10 Group B Friedman Test for Changes in Pressure Algometer Mean Values
Group B: Friedman Test
Group Reading Mean Rank P-Value
Group B
Visit 1 1.00 0.000 Visit 4 2.00
Visit 7 3.00
44
Table 4.10 demonstrates the results of the non-parametric Friedman test, which was
used to determine if there were changes of any statistical significant in pain pressure
threshold measured by the pressure algometer within group B over the trial period.
Group B had a mean rank pressure algometer value of 1.0 at the first visit, 2.0 at the
fourth visit, and 3.0 at the seventh visit. The p-value of 0.00 ≤ shows that the
improvement was statistically significant (p≤0.05).
Table 4.11 Group B Wilcoxon Signed-Rank Test for Changes over Time (Pressure Algometer)
Group B: Wilcoxon Signed-Rank Test
Visits P-Value
Visit 1 – Visit 4 0.001
Visit 4 – Visit 7 0.001
Visit 1 – Visit 7 0.001
Table 4.11 demonstrates the results from the Wilcoxon signed-rank test, a non-
parametric test, used to determine between which visits the statistically significant
improvement in pain pressure threshold measured by the pressure algometer
occurred in group B.
The statistically significant difference (p≤0.05) was found between the visit first and
fourth visits (p=0.001), between the fourth and seventh visits (p=0.001), and
between the first and seventh visits (p=0.001).
45
4.4.1.3 Clinical analysis
Figure 4.2 Changes in the Mean Pain Threshold of the Pressure Algometer for Group A and Group B
Figure 4.2 illustrates the mean values of the pressure algometer in kg/cm² for the
first, fourth, and the seventh visits. It indicates an overall increase in pain pressure
threshold.
4.4.2 Intergroup analysis of the pressure algometer
Table 4.12 Mann-Whitney U Test for Pressure Algometer Mean Values
Mann-Whitney U Test: Pressure Algometer
Readings Group A Group B
Visit 1 Mean Rank 18.43 12.57
p-value 0.065 thus p > 0.05
Visit 4 Mean Rank 16.96 14.03
p-value 0.36 thus p > 0.05
Visit 7 Mean Rank 16.23 14.77
5.04
6.21
7.43
4.54
5.99
7.25
0
1
2
3
4
5
6
7
8
Visit 1 Visit 4 Visit 7Pre
ssur
e A
lgom
eter
Mea
n V
alue
s (k
g/cm
²)
Group A Group B
46
p-value 0.65 thus > 0.05
Table 4.12 demonstrates the results from the non-parametric Mann-Whitney U test
that was used to compare mean rank pressure algometer values of the two groups.
The test determined whether the difference between the groups was purely by
chance or if it was statistically significant and revealing of the more superior
treatment.
The baseline reading of the p-value at visit 1 was 0.065, therefore the groups started
off comparable. The p-value remained greater at visit 4 (0.36) and at visit 7 (0.65). These results indicate no statistically significant difference (p>0.05) in the mean
pressure algometer readings between group A and group B.
4.4.3 Intragroup analysis of the baseline goniometer
4.4.3.1 Baseline goniometer statistics of group A
Table 4.13 Group A Column Statistics of the Baseline Goniometer
Group A: Baseline Goniometer (Degrees)
Readings Mean Maximum Minimum Median Std. Deviation
Visit 1 29.47 50 15 30 8.236
Visit 4 22.53 37 5 20 9.702
Visit 7 17.20 30 3 20 9.049
Table 4.13 illustrates the baseline goniometer mean, maximum, minimum, median
and standard deviation values of group A. The popliteal angle was measured from
90 degrees to 0 degrees. A decrease in degrees indicates an increase in hamstring
flexibility. Group A had a mean baseline goniometer reading of 29.47° at the first
visit, 22.53° at the fourth visit and 17.20° at the seventh visit. The mean percentage
47
change in hamstring extensibility measured by the baseline goniometer for group A
was 71.34 %.
Table 4.14 Group A Friedman Test for Changes in Baseline Goniometer Mean Values
Group A: Friedman Test
Group Reading Mean Rank P-Value
Group A
Visit 1 2.60 0.001 Visit 4 2.07
Visit 7 1.33
Table 4.14 demonstrates the results of the non-parametric Friedman test used to
determine if there were changes of any statistical significant in hamstring extensibility
measured by the baseline goniometer within group A over the trial period.
Group A had a mean rank baseline goniometer value of 2.60 at the first visit, 2.07 at
the fourth visit and 1.33 at the seventh visit. The p-value of 0.001 shows that the
improvement was statistically significant (p≤0.05).
Table 4.15 Group A Wilcoxon Signed-Rank Test for Changes over Time (Baseline Goniometer)
Group A: Wilcoxon Signed-Rank Test
Visits P-Value
Visit 1-Visit 4 0.017
Visit 4- Visit 7 0.029
Visit 1-Visit 7 0.002
48
Table 4.15 demonstrates the results of the Wilcoxon signed-rank test, used to
determine between which visits the statistically significant improvement in hamstring
extensibility measured by the baseline goniometer occurred in group A.
Results showed that statistically significant difference (p≤0.05) was found between
the first and the fourth visits (p=0.017), between the fourth and seventh visits
(p=0.029) and between the first and the seventh visits (p=0.002).
4.4.3.2 Baseline goniometer statistics of group B
Table 4.16 Group B Column Statistics of the Baseline Goniometer
Group B: Baseline Goniometer
Readings Mean Maximum Minimum Median Std. Deviation
Visit 1 35 55 20 35 9.636
Visit 4 22.67 35 5 25 8.633
Visit 7 20.13 40 5 19 10.253
Table 4.16 illustrates the baseline goniometer mean, maximum, minimum, median
and standard deviation values of Group B. The popliteal angle was measured from
90 degrees to 0 degrees. A decrease in degrees indicates an increase in hamstring
flexibility. At the first visit Group B had a mean baseline goniometer reading of
35.00°, at the fourth visit group B had a mean baseline goniometer reading of 22.67°, and at the seventh visit group B had a mean baseline goniometer reading of 20.13°. The mean percentage changes in hamstring extensibility measured by the baseline
goniometer for Group B was 73.87 %.
49
Table 4.17 Group B Friedman Test for Changes in Baseline Goniometer Mean Values
Group B: Friedman Test
Group Reading Mean Rank P-Value
Group B
Visit 1 2.93 0.000 Visit 4 1.73
Visit 7 1.33
Table 4.17 demonstrates the results of the non-parametric Friedman test used to
determine if there were changes of statistical significant in hamstring extensibility
measured by the baseline goniometer within group B over the trial period.
Group B had a mean baseline goniometer value of 2.93 at the first visit, 1.73 at the
fourth visit and 1.33 at the seventh visit. The p-value of 0.00 shows that the
improvement was statistically significant (p≤0.05).
The individual groups displayed a p-value of 0.00 ≤ 0.05. This indicates that over the
course of the trial, the improvement in hamstring extensibility measured by the
baseline goniometer was statistically significant. Further evaluation is necessary to
establish between which visits the improvement occurred. The Wilcoxon signed-rank
test was used to evaluate where the improvement occur.
Table 4.18 Group B Wilcoxon Signed-Rank Test for Changes over Time (Baseline Goniometer)
Group B: Wilcoxon Signed-Rank Test
Visits P-Value
Visit 1-Visit 4 0.001
Visit 4- Visit 7 0.220
50
Visit 1-Visit 7 0.001
Table 4.18 demonstrates the results of the Wilcoxon signed-rank test, a non-
parametric test used to determine between which visits the statistically significant
improvement in hamstring extensibility measured by the baseline goniometer
occurred in group B.
The statistically significant difference (p≤0.05) was found between the first and fourth
visits (p=0.001), and between the first and seventh visits (p=0.001). There was no
statistically difference (p>0.05) between visit four and visit seven (p=0.220).
4.4.3.2 Clinical analysis
Figure 4.3 Changes in the Mean Readings of Baseline Goniometer
Figure 4.3 illustrates the mean values of the baseline goniometer of both groups of
the first, fourth, and the seventh visits. It indicates an overall increase in hamstring
extensibility.
29.47
22.53
17.2
35
22.6720.13
0
5
10
15
20
25
30
35
40
Visit 1 Visit 4 Visit 7
Bas
elin
e G
onio
met
er (D
egre
es)
Group A Group B
51
4.4.4 Intergroup analysis of the baseline goniometer
Table 4.19 Mann-Whitney U test for Comparison of Baseline Goniometer Mean Values
Mann-Whitney U Vest: Baseline Goniometer
Readings Group A Group B
Visit 1 Mean Rank 12.20 18.80
p-value 0.063 thus p > 0.05
Visit 4 Mean Rank 15.37 15.63
P-value 0.93 thus p >0.05
Visit 7 Mean Rank 14.37 16.37
p-value 0.59 thus > 0.05
Table 4.19 demonstrates the results of the non-parametric Mann-Whitney U test that
was used to compare mean rank baseline goniometer values of the two groups. The
test determined whether the difference between the groups was purely by chance or
if it was statistically significant and revealing of the more superior treatment.
The baseline reading of the p-value at visit 1 (p=0.063) greater was than 0.05. The
p-value remained greater at visit 4 (0.93) and at visit 7 (0.59). Thus, there was no
statistically significant difference (p>0.05) in the mean baseline goniometer readings
between group A and group B.
52
CHAPTER FIVE: DISCUSSION
5.1 INTRODUCTION
The results presented in chapter four will be discussed in this chapter, particularity
those results that were of statistical significance. These findings will be compared
with the findings of previous research as discussed in the literature review presented
in chapter two, together with additional relevant research.
5.2 DEMOGRAPHIC DATA
5.2.1 Age and gender analysis
Participants between the ages of 18 and 50 years were used for this study. As
illustrated in table 4.1, the sample group was composed of 15 male and 15 female
participants, with a mean age of 25.07 years of age. The minimum age was 21 and
the maximum age was 32 years.
According to Vecchiet (2002), persons under the age of 50 years are the most likely
to have active myofascial trigger points, owing to the fact that persons of this age
group are the most active, therefore their muscles are more likely to be overused,
and have resulting micro-trauma.
5.3 SUBJECTIVE DATA
5.3.1 Intragroup analysis of the Numerical Pain Rating Scale
The results indicated that the ischemic compression group and the percussive
massage device group both demonstrated a statistically significant improvement
with regards to the NPRS values that were obtained over time. These statistically
significant changes were consistent throughout the treatment period.
53
5.3.1.1 Numerical Pain Rating Scale statistics for the ischemic compression group
The results from the Wilcoxon signed-rank test, demonstrated in table 4.3, indicated
that the ischemic compression group had a statistically significant improvement
(p≤0.05) over time from the first to the seventh treatment (p=0.001). Ischemic
compression on an active hamstring trigger point proved to have a statistically
significant improvement from the first visit to the fourth visit regarding pain perception
(p=0.001), as well as from the fourth visit to the seventh visit (p=0.001). The clinical
analysis also demonstrated that the ischemic compression group had a positive
affect over time, with decreasing pain perception of 74.66% when comparing the
measurements taken at the beginning of the trial to those taken at the end.
5.3.1.2 Numerical Pain Rating Scale statistics for the percussive massage device group
The results of the Wilcoxon signed-rank test, demonstrated in table 4.5, indicated
that the percussive massage device group had a statistically significant improvement
(p≤0.05) over time when comparing the results taken at the first visit to those from
the seventh (p=0.001). The test revealed that therapeutic massage with a percussive
device on an active hamstring trigger point proved to have a statistically significant
improvement regarding pain perception when comparing the results from the first
visit to those from the fourth visit (p=0.001), and the fourth visit to the seventh visit
(p=0.001). Clinical interpretation also showed that the percussive massage group
had a positive affect over time, with a decreasing pain perception of 76.15% from
the beginning of the trial to the end.
54
5.3.2 Intergroup analysis of the Numerical Pain Rating Scale
A comparison was made between the two groups at specific intervals using the
Mann-Whitney U test. Comparisons between the ischemic compression group and
the percussive massage group were made between the intervals of the first, fourth
and seventh visits. The first measurement had a p-value of 0.708, the fourth
measurement had a p-value of 0.931 and the seventh measurement had a p-value
of 0.983. Therefore, no significant differences (p>0.05) occurred between the two
groups at the specific time intervals with regards to pain perception.
5.3.3 Subjective data discussion
The results were conclusive in that there was a definite improvement in the extent of
the subjective pain perception experienced by both groups. When considering the
NPRS, the results indicate that both groups improved between the first and the
seventh visits. The ischemic compression group showed a more favorable
improvement than the percussive massage device group.
5.3.3.1 The effect of ischemic compression on pain perception
Ischemic compression is a non-invasive treatment method that causes temporary
decrease in blood within the myofascial trigger point in order to ultimately increase
the blood flow. The increase in blood to the myofascial trigger point flushes out the
waste product and the inflammatory exudate molecules from the myofascial trigger
point (Fritz and Grosenbach, 2009). This phenomenon then leads to an increase in
the local oxygen supply to the myofascial trigger point, allowing the affected tissue
to initiate the healing process (Arnau-Masanet et al., 2010).
Ischemic compression creates a mechanical disruption of the actin-myosin myofibril
cross links that are locked within the trigger point (Mense and Simons, 2000; Perle
et al., 1999). This disruption causes a decrease in sensory afferent input of noxious
55
stimuli to the brain via the pain gate theory (Mense et al., 2000). The pain relief
associated with ischemic compression is also linked with alternating spinal reflex
mechanisms that cause a decrease in muscle spasm (Ingbur, Kostopoulos, Larkin
and Nelson, 2008).
Behrangrad and Kamali (2017) similarly demonstrated a statistically significant
improvement (p ≤ 0.05) using the NPRS in a comparative study between ischemic
compression and lumbar pelvic manipulation as trigger point therapy for
patellofemoral pain syndrome in young adults. Ischemic compression showed to be
superior to lumbopelvic manipulation therapy in both the short and the long term with
regards to effectiveness for the treatment of patellofemoral pain syndrome.
Hou, Tsai, Cheng, Chung, and Hong (2002) investigated the immediate effect of
physical therapeutic modalities on myofascial pain in the upper trapezius muscle and
found that ischemic compression provided an immediate relieve in pain perception
and decreased the sensitivity of the myofascial trigger point.
5.3.3.2 The effect of therapeutic massage with a percussive device on pain perception
One of the reported benefits of device-assisted soft tissue manipulation is an
analgesic effect, which is a temporarily reduction or elimination of pain perceived.
Device-assisted soft tissue manipulation provides a noxious stimulation for pain
modulation, leading to an analgesic response. The pain gate theory asserts that the
pain signals are then inhibited, which could be a possible explanation for the
analgesic effect. Consequently, reduced pain lead to muscle relaxation, which allows
for normalised neuromuscular movement and improvement of the function of the soft
tissue. Soft tissue mechanotherapy is effective in treating pain, leading to muscle
relaxation (Weerapong, Hume and Kolt, 2005).
According to Frey, Evans, Knudtson, Nus, Scholl and Sluka (2008), device-assisted
soft tissue manipulation causes friction between the tissues that disrupt the tissue
56
and causes fibroblastic proliferation to the soft tissue, which results in tissue
regeneration and recovery. Scar tissue is broken down, which reinitiates the healing
process. This process begins with the increase of blood flow to the tissue, bringing
healing substances phagocytosed by white blood cells to the micro-injury site (area
of tissue disruption caused by the treatment). The repair process of the tissue leads
to less painful tissue.
5.4 OBJECTIVE DATA
5.4.1 Intragroup analysis of the pressure algometer
The results from the pressure algometer statistical analysis showed that both the
ischemic compression group and the percussive massage device group had
significant differences in the pressure algometer readings over time.
5.4.1.1 Pressure algometer statistics for the ischemic compression group
The results using the Wilcoxon signed-rank test, demonstrated in table 4.8, indicated
that the ischemic compression group had a statistically significant improvement
(p≤0.05) over time when comparing the results from the first to the seventh treatment
(p=0.001). Ischemic compression on an active hamstring trigger point proved to
have a statistically significant improvement with regards to pressure pain threshold
between the first visit and the fourth visit, (p=0.001), and between the fourth and the
seventh visit (p=0.003). The clinical interpretation also proved that ischemic
compression had a positive affect over time, with the group showing an increased
pressure pain threshold of 47.42% from the beginning of the trial to the end.
57
5.4.1.2 Pressure algometer statistics for the percussive massage device group
The results from the Wilcoxon signed-rank test, demonstrated in table 4.8, indicated
that the percussive massage device group had a statistically significant improvement
(p≤0.05) over time from the first visit to the seventh (p=0.001). The test revealed that
therapeutic massage with a percussive device on an active hamstring trigger point
proved to have a statistically significant improvement with regards to pressure pain
threshold between the first visit and the fourth visit (p=0.001), and the fourth visit and
the seventh visit (p=0.001). The clinical interpretation also proved that the
percussive massage device had a positive affect over time, with the group showing
and increased pressure pain threshold of 59.69% from the beginning of the trial to
the end.
5.4.2 Intergroup analysis of the pressure algometer
A comparison was made between the two groups at specific intervals using the
Mann-Whitney U test. Comparisons were made between the ischemic compression
group and the percussive massage group at the intervals of the first, fourth and
seventh visits. The first measurement had a p-value of 0.065, the fourth
measurement a p-value of 0.360 and the seventh a p-value of 0.650. Therefore, no
significant differences (p>0.05) occurred between the two groups at the specific time
intervals with regards to pressure pain threshold.
5.4.3 Discussion of pressure algometer results
5.4.3.1 The effect of ischemic compression on pain threshold
Dearing and Hamilton (2008) established that ischemic compression was a more
effective technique than the muscle energy technique in decreasing pressure pain
threshold in trigger points in asymptomatic patients. The effect of ischemic
compression therapy in increasing the pressure pain threshold may be attributed to
58
the reactive hyperemia caused by the temporarily occlusion of blood supply (Hou et
al., 2002). This reaction helps in flushing the muscle of inflammatory exudates and
pain metabolites, breaking down scar tissue and reducing muscle tone. Applying
direct ischemic compression diminishes the sensitivity of nodules (Travell and
Simons, 1999) and may restore the length of sarcomeres in the myofascial trigger
point (Simons, 2002). These changes may result in normal resting length of muscles.
5.4.3.2 The effect of a percussive massage device on pain threshold
According to Costantino, Galuppo, and Romiti (2017), vibration and percussion
devices have an effect in the pain gate theory by affecting the afferent discharge
from fast-adapting mechanoreceptors and muscle spindles, therefore decreasing the
pressure pain threshold.
It is thought that when vibration or percussion devices are applied directly on the
skin, the large afferent nerve fibers are activated and the small afferent nerve fibers
are inhibited. This process allows signals to be sent to the spinal cord from the large
fibers and not the small fibers, which normally transmit signals of pain, therefore
reducing the pain perceived as well as the pressure pain threshold (Magee,
Zachazewski and Quillen, 2007).
5.4.4 Intragroup analysis of the baseline goniometer
5.4.4.1 Baseline goniometer statistics for the ischemic compression group
The results of the Wilcoxon signed-rank test, demonstrated in table 4.15, indicated
that the ischemic compression group had a statistically significant improvement
(p≤0.05) over time when comparing the results from the first treatment to those of
the seventh treatment (p=0.002). The test revealed that ischemic compression on
an active hamstring trigger point proved to have a statistically significant
improvement with regards to pressure pain threshold between the first visit and the
59
fourth visit, (p=0.017), and the fourth visit and the seventh visit (p=0.029). The
clinical interpretation also proved that ischemic compression had a positive affect
over time, with this group showing an increased hamstring extensibility of 71.34 %
from the beginning of the trial to the end.
5.4.4.2 Baseline goniometer statistics for the percussive massage device group
The results of the Wilcoxon signed-rank test, demonstrated in table 4.18, indicated
that the percussive massage device group had a statistically significant improvement
(p≤0.05) over time when comparing results of the first visit to those of the seventh
(p=0.001). The test revealed that therapeutic massage with a percussive device on
an active hamstring trigger point proved to have a statistically significant
improvement with regards to pressure pain threshold between the first visit and the
fourth visit (p=0.001).There was no statistically difference between (p>0.05) the
fourth and the seventh visits (p=0.220). The clinical interpretation also proved that
percussive massaging had a positive affect over time, with this group showing an
increased hamstring extensibility of 73.87 % from the beginning of the trial to the
end.
5.4.5 Intergroup analysis of the baseline goniometer
A comparison was made between the two groups at specific intervals using the
Mann-Whitney U test. Comparisons between the ischemic compression group and
the percussive massage group were made between the intervals of the first, fourth
and seventh visits. The first measurement had a p-value of 0.063, the fourth
measurement had a p-value of 0.930 and the seventh measurement had a p-value
of 0.590. Therefore, no significant differences (p>0.05) occurred between the two
groups at the specific time intervals with regards hamstring extensibility.
60
5.4.6 Discussion of the baseline goniometer results
5.4.6.1 The effect of ischemic compression on hamstring extensibility
Desai and Jeswani (2018) compared the effectiveness of myofascial release and
ischemic compression on acute trapezitis in young adults between the ages of 18
and 30. The results show that both the techniques were effective in reducing pain
and neck disability and increasing cervical lateral flexion in the tested subjects.
Aguilera, Martin, Masanet, Botella, Soler and Morell (2009) compared the immediate
effects of ischemic compression and ultrasound for the treatment of latent myofascial
trigger points in the trapezius muscle. The results revealed an immediate decrease
in electrical activity of the trapezius muscle and a decrease of myofascial trigger
point sensitivity after both types of treatment, while improvement in the active
cervical range of motion was only noted in the ischemic compression group only.
As mentioned in section 5.4.3.1, ischemic compression therapy increases the
pressure pain threshold due to reactive hyperemia caused by the temporarily
constriction of blood supply (Hou et al., 2002), which then flushes the muscle of
inflammatory exudates and pain metabolites, breaks down scar tissue and reduces
muscle tone. These processes then reduce the of sensitivity of the myofascial trigger
point (Travell and Simons, 1999) and restore the length of sarcomeres in the
myofascial trigger point (Simons, 2002). These changes may result in normal resting
length of muscles, therefore increasing the flexibility of the muscle.
5.4.6.2 The effect of a therapeutic massage with a percussive device on hamstring extensibility
Issurin (2005) suggests that percussive massage devices may enhance excitatory
inflow from the muscle spindles to the alpha motor neuron pools and control the
recruitment thresholds and firing rates of motor units. They also decrease the
inhibitory impact of the Golgi tendon organs, providing more flexibility.
61
Furthermore, Bakhtiary et al. (2011) report a general increase in range of motion and
flexibility of the hamstring muscle in their investigation of the application of device-
assisted soft tissue manipulation on hamstring extensibility.
Finally, percussive massage devices create mechanical pressure on the muscle
tissue in order to decrease adhesions in the tissue. Mobilising and elongating
shortened or adhered connective tissue may increase muscle-tendon compliance.
Improved muscle compliance results in a less stiff muscle-tendon unit. These effects
help to restore muscle flexibility and restoring range of motion (Imtiyaz, Veqar,
Shareef (2014).
62
CHAPTER SIX: CONCLUSION AND RECOMMENDATIONS
6.1 CONCLUSION
The aim of this study was to compare the efficacy of ischemic compression with that
of therapeutic massage with a percussive device in the treatment of active hamstring
trigger point pain. The outcome of this study suggested that patients with hamstring
trigger point pain were treated effectively with either, as active trigger points respond
well to both ischemic compression and therapeutic massage with a percussive
device. Both groups showed a reduction in self-reported pain, an increase in pain
pressure threshold and an increase in hamstring extensibility over active hamstring
trigger points.
The results of this study showed that the clinical difference was statistically
insignificant (p<0.05). In conclusion, no treatment intervention was superior to the
other in treating active hamstring trigger points. Statistical results indicate that both
treatment interventions are effective in reducing hamstring pain and increasing the
hamstring extensibility.
This study thus indicated that both ischemic compression and therapeutic massage
with a percussive device were used to treat hamstring trigger point pain effectively
provided that no contraindications were present. In the case of patient being
contraindicated to one treatment intervention, the other is a suitable alternative.
The clinical importance of this study provides the chiropractic profession with two
different treatment interventions to effectively treat patients with hamstring
myofascial trigger point pain. Numerous studies have been done to determine the
effect of chiropractic manipulative therapy on myofascial trigger points, as it is the
profession’s primary treatment intervention. Ischemic compression and therapeutic
massage with a device, however, could serve as an effective post manipulative or
alternative treatment interventions to spinal manipulation. The device-assisted soft
tissue manipulation could also help prevent or reduce fatigue and injuries in manual
therapists.
63
6.2 RECOMMENDATIONS
The following recommendations should be taken into consideration for further
research regarding the treatment of active hamstring myofascial trigger points:
A larger sample size should be used to offer generalisability.
The long-term effects of both treatment interventions can be investigated by
increasing the treatment period or adding a one month follow-up after the
completion of the six treatments.
The effect of a combination of ischemic compression and therapeutic
massage with a percussive massage should be examined in the treatment of
active hamstring myofascial trigger points.
A research study should be done with two sample groups, one receiving a
sacroiliac chiropractic manipulation and ischemic compression, with the other
receiving chiropractic sacroiliac manipulation and therapeutic massage with
a percussive device. Doing so could provide a comparison of chiropractic
manipulation interventions.
An additional objective measurement could be added to assess range of
motion or muscle strength. Doing so could provide more information on the
different physiological effects of the two treatment interventions.
64
REFERENCES Arnau-Masanet, R., Barrios-Pitarque, C., Bosch-Morell, F., Montanez-Aguilera, F.J.,
Pecos-Martin, D. and Valtuena-Gimeno, N., (2010). Changes in a patient with neck
pain after application of ischemic compression as a trigger point therapy. Journal of
Back and Musculoskeletal Rehabilitation, 23(2):101-104.
construct validity, and responsiveness of the neck disability index, patient-specific
functional scale, and numeric pain rating scale in patients with cervical radiculopathy.
American Journal of Physical Medicine and Rehabilitation, 89(10): 831-839.
75
APPENDIX A: ADVERTISEMENT
Research study Are you between the ages of 18-50? Do you suffer from hamstring pain?
Are you currently not receiving any treatment for your pain?
You may be eligible to participate in my research study, which aims to compare the effects of ischemic compression with therapeutic massage with a percussive
device in treating hamstring pain.
The research will be conducted at the Chiropractic Clinic at the University of Johannesburg Doornfontein Campus.
If you are interested in taking part, please contact: Charlize Jonker
My name is Charlize Jonker. I WOULD LIKE TO INVITE YOU TO PARTICIPATE in a research study, on ‘The effect of ischemic compression versus therapeutic massage with a percussive device in treating hamstring myofascial pain dysfunction.’
Before you decide on whether to participate, I would like to explain to you why the research is being done and what it will involve for you. I will go through the information letter with you and answer any questions you have. This should take about 10 to 20 minutes. The study is part of a research project being completed as a requirement for a Master’s Degree in Chiropractic through the University of Johannesburg.
THE PURPOSE OF THIS STUDY is to compare the effects of ischemic compression versus therapeutic massage with a percussive device in treating active myofascial hamstring trigger points.
Below, I have compiled a set of questions and answers that I believe will assist you in understanding the relevant details of participation in this research study. Please read through these. If you have any further questions I will be happy to answer them for you.
DO I HAVE TO TAKE PART? No, you don’t have to. It is up to you to decide to participate in the study. I will describe the study and go through this information sheet. If you agree to take part, I will then ask you to sign a consent form.
77
WHAT EXACTLY WILL I BE EXPECTED TO DO IF I AGREE TO PARTICIPATE? You must be between ages of 18-50, with localised pain that is concentrated in the hamstring region. You will not be included in to the study if you have any of the following: trauma or surgeries to the region, tumors or infection, or a rupture of any of the hamstring muscle. If you qualify to participate in this study, you would not be able to participate in any other research studies during this time nor take any medications that may influence the outcomes of this study. Not all medications may be a problem, so please be open with me regarding any medication or supplements you are using. Also, please be open with me regarding your health history, since you may otherwise harm yourself by participating in this study.
You will be allocated to one of two groups consisting of 15 participants. You will then be assigned to your group by drawing a number from a hat. The hat will contain 30 pieces of paper labelled A or B (representing the group numbers). The number you draw is the group you will be allocated to. Group A will only receive treatment in the form of ischemic compression on hamstring myofascial trigger points, meaning the researcher will apply localised pressure on the hamstring muscle trigger point. Group B will receive a therapeutic massage with a device that vibrates on the hamstring muscle.
A case history, physical examination and a lower back examination will be performed. A series of tests will be gathered for data collection. The first test is a Numerical Pain Rating Scale. You will be asked to rate your pain on a scale of 0 to 10, i.e. from no pain and to the worse pain you have ever experienced. Thereafter the researcher will locate a trigger point that reproduces the pain on the hamstring region. The researcher will the preform a test with a pressure algometer to record your pain threshold. Thereafter you will be positioned on your back with your knee and your hip bend to 90 degrees. The researcher will use a baseline goniometer to measure the popliteal angle, e.g. you will try to straighten your leg as far as possible and the researcher will measure the angel of your knee.
Thereafter you will be treated for the duration of 60 seconds. You will be treated over a three-week period, twice per week, and the seventh visit will be for data collection only.
WHAT WILL HAPPEN IF I WANT TO WITHDRAW FROM THE STUDY? If you decide to participate, you are free to withdraw your consent at any time without giving a reason and without any consequences. If you wish to withdraw your consent, you must please inform me as soon as possible.
IF I CHOOSE TO PARTICIPATE, WILL THERE BE ANY EXPENSES FOR ME, OR PAYMENT DUE TO ME? You will not be paid to participate in this study and you will not bear any expenses either.
78
RISKS INVOLVED IN PARTICIPATION: Ischemic compression and therapeutic massage with a vibrating device are not harmful to the participant. The massage device may cause some itching or a warm sensation due to the increasing blood flow to the area. You might also have slight discomfort over the trigger point, which is completely normal. With the ischemic compression group, you might have a slight discomfort when the pressure is applied on the point of pain. You might a small bruise but the chances of bruising are minimal.
BENEFITS INVOLVED IN PARTICIPATION: Therapeutic massage with a vibrating device is aimed at decreasing muscle spasm and pain, increasing the blood flow to the area, which will stimulate healing and improve the function of the muscle. During ischemic compression the researcher will apply pressure to the myofascial trigger point causing hypoxia (decrease of blood flow) to the trigger point. The pressure will be released after 60 seconds, causing an influx of blood to stimulate healing.
WILL MY PARTICIPATION IN THIS STUDY BE KEPT CONFIDENTIAL? Yes. Names on the data sheet will be removed once analysis starts. All data and back-ups thereof will be kept in password-protected folders and/or locked away as applicable. Only I or my research supervisor will be authorised to use and/or disclose your anonymised information in connection with this research study. Any other person wishing to work with you anonymised information as part of the research process (e.g. an independent data coder) will be required to sign a confidentiality agreement before being allowed to do so.
OR
WILL MY TAKING PART IN THIS STUDY BE ANONYMOUS? Yes. Anonymous means that your personal details will not be recorded anywhere by me. As a result, it will not be possible for me or anyone else to identify your responses once these have been submitted.
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY? The results will be written into a research report that will be assessed. In some cases, results may also be published in a scientific journal. In either case, you will not be identifiable in any documents, reports or publications. You will be given access to the study results if you would like to see them, by contacting me.
WHO IS ORGANISING AND FUNDING THE STUDY? The study is being organised by me, under the guidance of my research supervisor at the Department of Chiropractic in the University of Johannesburg. All funding for the study will be provided by the supervisor-linked bursary.
WHO HAS REVIEWED AND APPROVED THIS STUDY? Before this study was allowed to start, it was reviewed in order to protect your interests. This review was
79
done first by the Department of Chiropractic, and then by the Faculty of Health Sciences Research Ethics Committee at the University of Johannesburg. In both cases, the study was approved.
WHAT IF THERE IS A PROBLEM? If you have any concerns or complaints about this research study, its procedures or risks and benefits, you should ask me. You should contact me at any time if you feel you have any concerns about being a part of this study. My contact details are:
If you feel that any questions or complaints regarding your participation in this study have not been dealt with adequately, you may contact the Chairperson of the Faculty of Health Sciences Research Ethics Committee at the University of Johannesburg:
Prof. Christopher Stein Tel: 011 559-6564 Email: [email protected] FURTHER INFORMATION AND CONTACT DETAILS: Should you wish to have more specific information about this research project information, or have any questions, concerns or complaints about this research study, its procedures, risks and benefits, you should communicate with me using any of the contact details given above.
The effects of ischemic compression versus therapeutic massage with a percussive device in treating hamstring myofascial pain dysfunction
Please initial each box below:
I confirm that I have read and understand the information letter dated 19/07/2016 for the above study. I have had the opportunity to consider the information and ask questions, and have had these answered satisfactorily.
I understand that my participation is voluntary and that I am free to withdraw from this study at any time without giving any reason and without any consequences to me.
Please indicate the intensity of current, best, and worst pain levels over the past 24
hours on a Scale of 0 (no pain) to 10 (worst pain imaginable) |______|______|______|______|______|______|______|______|______|______|
0 1 2 3 4 5 6 7 8 9 10
No pain Mild Pain Moderate Pain Worst
Visit 4: Patient Instructions
Please indicate the intensity of current, best, and worst pain levels over the past 24
hours on a Scale of 0 (no pain) to 10 (worst pain imaginable) |______|______|______|______|______|______|______|______|______|______|
0 1 2 3 4 5 6 7 8 9 10
No pain Mild Pain Moderate Pain Worst
Visit 7 Patient Instructions
Please indicate the intensity of current, best, and worst pain levels over the past 24
hours on a Scale of 0 (no pain) to 10 (worst pain imaginable) |______|______|______|______|______|______|______|______|______|______|
0 1 2 3 4 5 6 7 8 9 10
No pain Mild Pain Moderate Pain Worst
94
APPENDIX H: HAMSTRING TRIGGER POINT EXAMINATION
File Number:
Date:
L R
Spot Tenderness: Yes / No
Referred Pain: Yes / No
Where:
95
APPENDIX I: PRESSURE ALGOMETER AND GONIOMETER READINGS
Research file number:
Hamstring muscle trigger point:
Readings Date Algometer (kg/cm²)
Goniometer Degrees
Visit 1
Visit 4
Visit 7
96
APPENDIX J: LETTER OF REQUEST
To the division for institutional planning, evaluation and monitoring management, I would like to ask permission to perform my research on the University of Johannesburg Doornfontein Campus. The research will take place at the Chiropractic Clinic with possible involvement of students studying on this campus. The study is titled ‘The effect of ischemic compression versus therapeutic massage with a percussive device on hamstring myofascial pain dysfunction.’ Thirty participants will be involved in twice-a-week consultation for three weeks.
This study has been approved by the University of Johannesburg’s Ethics